189 related articles for article (PubMed ID: 26670277)
1. In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation.
Cortez MA; Valdecanas D; Niknam S; Peltier HJ; Diao L; Giri U; Komaki R; Calin GA; Gomez DR; Chang JY; Heymach JV; Bader AG; Welsh JW
Mol Ther Nucleic Acids; 2015 Dec; 4(12):e270. PubMed ID: 26670277
[TBL] [Abstract][Full Text] [Related]
2. MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells.
He X; Yang A; McDonald DG; Riemer EC; Vanek KN; Schulte BA; Wang GY
Oncotarget; 2017 Sep; 8(41):69797-69807. PubMed ID: 29050242
[TBL] [Abstract][Full Text] [Related]
3. Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo.
Li J; Zhong X; Zhao Y; Shen J; Xiao Z; Pilapong C
Sci Rep; 2024 Jan; 14(1):2348. PubMed ID: 38287075
[TBL] [Abstract][Full Text] [Related]
4. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
Shi Y; Liu C; Liu X; Tang DG; Wang J
PLoS One; 2014; 9(3):e90022. PubMed ID: 24595209
[TBL] [Abstract][Full Text] [Related]
5. MiR-34s negatively regulate homologous recombination through targeting RAD51.
Chen S; Liu R; Wang Q; Qi Z; Hu Y; Zhou P; Wang Z
Arch Biochem Biophys; 2019 May; 666():73-82. PubMed ID: 30951682
[TBL] [Abstract][Full Text] [Related]
6. PDL1 Regulation by p53 via miR-34.
Cortez MA; Ivan C; Valdecanas D; Wang X; Peltier HJ; Ye Y; Araujo L; Carbone DP; Shilo K; Giri DK; Kelnar K; Martin D; Komaki R; Gomez DR; Krishnan S; Calin GA; Bader AG; Welsh JW
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26577528
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway.
Duan W; Xu Y; Dong Y; Cao L; Tong J; Zhou X
J Radiat Res; 2013 Jul; 54(4):611-9. PubMed ID: 23349340
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis.
Li YL; Liu XM; Zhang CY; Zhou JB; Shao Y; Liang C; Wang HM; Hua ZY; Lu SD; Ma ZL
Oncogenesis; 2017 Aug; 6(8):e372. PubMed ID: 28825720
[TBL] [Abstract][Full Text] [Related]
11. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
Gupta S; Hashimoto RF
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327612
[TBL] [Abstract][Full Text] [Related]
12. Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer.
Zheng F; Li J; Ma C; Tang X; Tang Q; Wu J; Chai X; Xie J; Yang XB; Hann SS
J Cell Mol Med; 2020 May; 24(10):5578-5592. PubMed ID: 32248643
[TBL] [Abstract][Full Text] [Related]
13. Quercetin and Isorhamnetin Reduce Benzo[a]pyrene-Induced Genotoxicity by Inducing RAD51 Expression through Downregulation of miR-34a.
Kim M; Jee SC; Shin MK; Han DH; Bu KB; Lee SC; Jang BY; Sung JS
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361910
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer.
Qiao X; Zhao F
Bioengineered; 2022 Apr; 13(4):9264-9273. PubMed ID: 35411833
[TBL] [Abstract][Full Text] [Related]
15. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.
Song C; Lu P; Sun G; Yang L; Wang Z; Wang Z
Biochem Biophys Res Commun; 2017 Jan; 482(1):22-27. PubMed ID: 27836543
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibits proliferation of and induces apoptosis in non-small-cell lung carcinoma via the lncRNA SNHG7/miR-34a-5p pathway.
Chai R; Xu C; Lu L; Liu X; Ma Z
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):693-703. PubMed ID: 34448661
[TBL] [Abstract][Full Text] [Related]
17. 2-methoxyestradiol restrains non-small cell lung cancer tumorigenesis through regulating circ_0010235/miR-34a-5p/NFAT5 axis.
Zhang Y; Mi Y; He C
Thorac Cancer; 2023 Aug; 14(22):2105-2115. PubMed ID: 37439026
[TBL] [Abstract][Full Text] [Related]
18. miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.
Ruan L; Chen J; Ruan L; Tan A; Wang P
Int J Clin Exp Pathol; 2018; 11(3):1135-1145. PubMed ID: 31938208
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
20. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
